Blood transfusion therapy for β-thalassemia major and hemoglobin E β-thalassemia: Adequacy, trends, and determinants in Sri Lanka.

MLA

Mettananda, Sachith, et al. “Blood Transfusion Therapy for β-Thalassemia Major and Hemoglobin E β-Thalassemia: Adequacy, Trends, and Determinants in Sri Lanka.” Pediatric Blood & Cancer, vol. 66, no. 5, May 2019, p. e27643. EBSCOhost, https://doi.org/10.1002/pbc.27643.

APA

Mettananda, S., Pathiraja, H., Peiris, R., Wickramarathne, N., Bandara, D., de Silva, U., Mettananda, C., & Premawardhena, A. (2019). Blood transfusion therapy for β-thalassemia major and hemoglobin E β-thalassemia: Adequacy, trends, and determinants in Sri Lanka. Pediatric Blood & Cancer, 66(5), e27643. https://doi.org/10.1002/pbc.27643

Chicago

Mettananda, Sachith, Hashan Pathiraja, Ravindu Peiris, Nethmi Wickramarathne, Dayananda Bandara, Udaya de Silva, Chamila Mettananda, and Anuja Premawardhena. 2019. “Blood Transfusion Therapy for β-Thalassemia Major and Hemoglobin E β-Thalassemia: Adequacy, Trends, and Determinants in Sri Lanka.” Pediatric Blood & Cancer 66 (5): e27643. doi:10.1002/pbc.27643.